Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rajan Saggar
With
Actelion
The purpose of this study was to evaluate bosentan in the setting of exercise or resting pulmonary hypertension in patients with underlying pulmonary fibrosis.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Idiopathic Pulmonary Fibrosis referred for lung transplantation
Minimum 50 meter 6 minute walk distance
No significant underlying liver disease
You may not be if
Significant liver disease or cirrhosis
non ambulatory
previous adverse reaction/allergy to Bosentan
Clareo Health | Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
